FDAnews
www.fdanews.com/articles/142774-glenmark-pharma-gains-as-anti-diarrheal-drug-enters-pivotal-trials

Glenmark Pharma Gains as Anti-Diarrheal Drug Enters Pivotal Trials

December 28, 2011
Glenmark Pharmaceuticals shares rose after the company said it has obtained the DCGI (India) approval for conduct of the pivotal study of Crofelemer in acute watery diarrhea patients.
IndiaInfoLine